PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.





YEAR: 1983




CATEGORY: Contraception (Birth Control) and Family Planning



TITLE



Non-hormonal methods of contraception in diabetic women: reliability, risks,

precautions, follow-up. [Methodes non hormonales de contraception chez les

femmes diabetiques: fiabilite, risques, precautions, surveillance.]



AUTHORS

Buchsenschutz D


SOURCE

Journees Annuelles de Diabetologie de L Hotel-Dieu. 1983 May 5-7;:239-52.



ABSTRACT

Their lack of secondary effects on glucose metabolism, lipids, and coagulation factors make nonhormonal

contraceptive methods appropriate for diabetic women. The effectiveness and risks of nonhormonal contraceptive

methods in diabetic women are however not well known because of the lack of relevant studies. IUDs were until

recently regarded as a good method for diabetic women because of their effectiveness, absence of effects on ovarian

function, reversibility, lack of metabolic repercussions, and ease of use. A 1980 publication which reported 11

pregnancies among 30 diabetic women using IUDs prompted a review of the subject and a search for possible

factors responsible for the elevated failure rate. Copper IUDs, currently the most widely used, are lighter than inert

devices and are of various forms. Like other IUDs, they function by reducing chances of fertilization, preventing

implantation, and perhaps favoring destruction of the ovum. Factors in failure of IUDs include defective placement,

the most common; secondary displacement and expulsion; alterations to the IUD in the uterus; or possibly the

influence of some drugs such as antiprostaglandins. Other studies failed to disclose a higher rate of IUD failure

among diabetics, and the 1980 study that did so was criticized for inappropriate controls, insufficient documentation,

and failure to specify follow-up or surveillance of the patients. It is possible that the rate of expulsion is higher in

diabetic women but this hypothesis is not yet proven. Diabetes does not seem to be associated with a spectacular

increase in incidence of salpingitis in IUD users, but the consequences of an infection on the disease and for later

fertility justify vigilance in patient follow-up. No case of ectopic IUD was reported in 3 studies of IUD use by

diabetics, and the IUD does not seem to be associated with an elevated incidence of bleeding or pain. At present

there is no reason to modify the rules commonly in use for IUDs among other women specifically for diabetics, but

contraindications and other precautions must be scrupulously observed. All diabetic multiparas without known

antecedents of salpingitis can benefit from IUD use, but use should be discouraged in nulliparous diabetics. The

goals of surveillance include decreasing the risks of defective placement, displacement, and complications.

Diaphragms, vaginal spermicides, and condoms are free of metabolic effects but less effective than IUDs. Natural

methods should be discouraged in diabetic women because of their lower efficacy. (PubHealth.info Document ID:

CONT5T 2040-06)



PubHealth.info NOTE: The author(s) of this article titled, "Non-hormonal methods of contraception in diabetic

women: reliability, risks, precautions, follow-up. [Methodes non hormonales de contraception chez les femmes

diabetiques: fiabilite, risques, precautions, surveillance.]", is(are) Buchsenschutz D. The source of this article is

"Journees Annuelles de Diabetologie de L Hotel-Dieu. 1983 May 5-7;:239-52.". This article was published in 1983 in

French language(s). (PubHealth.info® Document ID: CONT5T 2040-06. All rights reserved with PubHealth.info) PIN:

22040




 

 

Web

PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.